Dark Forest Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,479
Closed -$769K 1041
2024
Q3
$769K Sell
1,479
-409
-22% -$218K 0.1% 233
2024
Q2
$1.02M Buy
+1,888
New +$998K 0.19% 104
2023
Q4
Sell
-3,945
Closed -$1.72M 658
2023
Q3
$1.72M Buy
3,945
+2,109
+115% +$957K 0.13% 190
2023
Q2
$816K Buy
1,836
+1,440
+364% +$664K 0.08% 384
2023
Q1
$182K Buy
396
+329
+491% +$157K 0.04% 430
2022
Q4
$34.4K Buy
67
+65
+3,250% +$33K 0.01% 461
2022
Q3
$1K Buy
+2
New +$957 ﹤0.01% 1044
2022
Q2
Sell
-80
Closed -$39K 1018
2022
Q1
$39K Buy
80
+44
+122% +$20.1K 0.01% 643
2021
Q4
$17K Sell
36
-282
-89% -$119K 0.01% 735
2021
Q3
$119K Buy
+318
New +$121K 0.04% 340

Other funds holding ELV

Dark Forest Capital Management's ELV Position: Q4 2024 in Review

Dark Forest Capital Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,479 shares — an estimated $769K sold.

Dark Forest Capital Management first reported a position in ELV in Q3 2021 and held it in 10 quarters. The position peaked at $1.72M in Q3 2023. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Dark Forest Capital Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Dark Forest Capital Management sold 1,479 Elevance Health shares in Q4 2024, an estimated $769K.
  • Dark Forest Capital Management first reported a position in Elevance Health in Q3 2021 and held it in 10 quarters.
  • Dark Forest Capital Management's Elevance Health position peaked at $1.72M in Q3 2023.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Dark Forest Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.